SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$32.88−0.44 (-1.32%)
Close on Nov 13, 2026Market cap $1.10BP/E –Yield –
SpyGlass Pharma cash
Cash and short-term investments held at the end of each period.
SpyGlass Pharma's cash was $208.69M at Sep 30, 2026. For fiscal 2025 it was $96.36M, up 492.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.36M | +492.3% |
| FY2024 | Dec 31, 2024 | $16.27M | +2.6% |
| FY2023 | Dec 31, 2023 | $15.85M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $208.69M | +96.9% |
| Q2 FY2026 | Jun 30, 2026 | $223.14M | +75.4% |
| Q1 FY2026 | Mar 31, 2026 | $238.90M | +311.9% |
| Q4 FY2025 | Dec 31, 2025 | $96.36M | +492.3% |
| Q3 FY2025 | Sep 30, 2025 | $106.01M | +568.9% |
| Q2 FY2025 | Jun 30, 2025 | $127.24M | – |
| Q1 FY2025 | Mar 31, 2025 | $58.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $16.27M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.85M | – |
See a number that looks wrong?